(Q53915277)

22 May 2018

title

Early Molecular Response of Marrow Disease to Biologic Therapy Is Highly Prognostic in Neuroblastoma (English)

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.11.077

20 March 2024

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.11.077

20 March 2024

4

Nai-Kong V. Cheung

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14551304

20 March 2024

1

Irene Y. Cheung

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14551304

20 March 2024

3

Brian H. Kushner

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14551304

20 March 2024

author name string

M. Serena Lo Piccolo

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14551304

20 March 2024

language of work or name

English

0 references

publication date

1 October 2003

1 reference

22 May 2018

15 October 2003

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14551304

full work available at URL

20 March 2024

https://ascopubs.org/doi/pdfdirect/10.1200/JCO.2003.11.077

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.11.077

Journal of Clinical Oncology

20 March 2024

published in

1 reference

22 May 2018

volume

21

1 reference

22 May 2018

issue

20

1 reference

22 May 2018

page(s)

3853-3858

1 reference

22 May 2018

Multivariate analysis of risk factors in stage 4 neuroblastoma patients over the age of one year treated with megatherapy and stem-cell transplantation: a report from the European Bone Marrow Transplantation Solid Tumor Registry.

cites work

1

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.11.077

Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group

20 March 2024

2

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.11.077

Anti-G(D2) antibody treatment of minimal residual stage 4 neuroblastoma diagnosed at more than 1 year of age

20 March 2024

3

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.11.077

A phase I/IB trial of murine monoclonal anti-GD2 antibody 14.G2a plus interleukin-2 in children with refractory neuroblastoma: a report of the Children's Cancer Group

20 March 2024

4

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.11.077

Phase I study of chimeric human/murine anti-ganglioside G(D2) monoclonal antibody (ch14.18) with granulocyte-macrophage colony-stimulating factor in children with neuroblastoma immediately after hematopoietic stem-cell transplantation: a Children's

20 March 2024

6

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.11.077

Phase II trial of the anti-G(D2) monoclonal antibody 3F8 and granulocyte-macrophage colony-stimulating factor for neuroblastoma

20 March 2024

7

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.11.077

Genomic organization and chromosomal assignment of the human beta1, 4-N-acetylgalactosaminyltransferase gene. Identification of multiple transcription units

20 March 2024

9

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.11.077

GD2 synthase: a new molecular marker for detecting neuroblastoma

20 March 2024

12

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.11.077

Ganglioside GM2/GD2 synthetase mRNA is a marker for detection of infrequent neuroblastoma cells in bone marrow

20 March 2024

13

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.11.077

Quantitation of GD2 synthase mRNA by real-time reverse transcription-polymerase chain reaction: utility in bone marrow purging of neuroblastoma by anti-GD2 antibody 3F8

20 March 2024

14

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.11.077

Quantitation of GD2 synthase mRNA by real-time reverse transcriptase polymerase chain reaction: clinical utility in evaluating adjuvant therapy in neuroblastoma

20 March 2024

15

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.11.077

Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment.

20 March 2024

16

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.11.077

Disialoganglioside GD2 anti-idiotypic monoclonal antibodies

20 March 2024

17

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.11.077

Detection of metastatic neuroblastoma in bone marrow: when is routine marrow histology insensitive?

20 March 2024

18

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.11.077

Minimal residual disease in solid tumor malignancies: a review

20 March 2024

20

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.11.077

Quantitative tumor cell content of bone marrow and blood as a predictor of outcome in stage IV neuroblastoma: a Children's Cancer Group Study.

20 March 2024

21

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.11.077

Prognostic significance of GAGE detection in bone marrows on survival of patients with metastatic neuroblastoma

20 March 2024

22

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.11.077

Circulating neuroblastoma cells detected by reverse transcriptase polymerase chain reaction for tyrosine hydroxylase mRNA are an independent poor prognostic indicator in stage 4 neuroblastoma in children over 1 year

20 March 2024

23

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.11.077

Real-time quantitative PCR for the detection of minimal residual disease in acute lymphoblastic leukemia using junctional region specific TaqMan probes

20 March 2024

24

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.11.077

Simultaneous detection and quantification of minimal residual disease in childhood acute lymphoblastic leukaemia using real-time polymerase chain reaction

20 March 2024

25

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.11.077

Application of germline IGH probes in real-time quantitative PCR for the detection of minimal residual disease in acute lymphoblastic leukemia

20 March 2024

26

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.11.077

Early response to therapy and outcome in childhood acute lymphoblastic leukemia: a review

20 March 2024

27

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.11.077

Minimal residual disease after intensive induction therapy in childhood acute lymphoblastic leukemia predicts outcome

20 March 2024

28

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.11.077

Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood.

20 March 2024

29

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.11.077

20 March 2024

Identifiers

1 reference

22 May 2018

1 reference

22 May 2018